Cite
Murphy P, Glynn D, Dias S, et al. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technol Assess. 2021;25(76):1-228doi: 10.3310/hta25760.
Murphy, P., Glynn, D., Dias, S., Hodgson, R., Claxton, L., Beresford, L., Cooper, K., Tappenden, P., Ennis, K., Grosso, A., Wright, K., Cantrell, A., Stevenson, M., & Palmer, S. (2021). Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health technology assessment (Winchester, England), 25(76), 1-228. https://doi.org/10.3310/hta25760
Murphy, Peter, et al. "Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework." Health technology assessment (Winchester, England) vol. 25,76 (2021): 1-228. doi: https://doi.org/10.3310/hta25760
Murphy P, Glynn D, Dias S, Hodgson R, Claxton L, Beresford L, Cooper K, Tappenden P, Ennis K, Grosso A, Wright K, Cantrell A, Stevenson M, Palmer S. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technol Assess. 2021 Dec;25(76):1-228. doi: 10.3310/hta25760. PMID: 34990339.
Copy
Download .nbib